SK

Shilpa Khanna Sahi

Active Director Director DIN 10117713
DIN 10117713 First appointment Apr 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Shilpa Khanna Sahi

Data last updated:

Shilpa Khanna Sahi is a Director at Crest Lifesciences Private Limited (since 2023). The company operates in Pharma. Crest Lifesciences Private Limited reported revenue of ₹41.71 Cr (FY 2025).

DIN 10117713
Primary Designation Director
Industry Pharma
First Appointment 17 Apr 2023
Oldest Company Age 11 yrs
Largest company Crest Lifesciences Private Limited · ₹41.71 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Crest Lifesciences Private Limited U24130HP2015PTC000969
Director17 Apr 20232015₹41.71 Cr (FY 2025)Active

Board colleagues of Shilpa Khanna Sahi

NameDINCompanyDesignation
Sunil Kumar Agarwal08676321Crest Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Crest Lifesciences Private Limited
Premium access

Shareholding and investment profile for Shilpa Khanna Sahi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shilpa Khanna Sahi

Shilpa Khanna Sahi currently holds 1 directorship: Crest Lifesciences Private Limited (Director, since 17 Apr 2023, revenue ₹41.71 Cr (FY 2025)).

Shilpa Khanna Sahi was first appointed on 17 Apr 2023 as Director at Crest Lifesciences Private Limited.

The current boards of Shilpa Khanna Sahi's companies include Sunil Kumar Agarwal (Crest Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available